Evidence map›Paper›PMID 39226363›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2024

Inhibition of colorectal cancer in Alzheimer's disease is mediated by gut microbiota via induction of inflammatory tolerance.

Nan Zhang, Rui Zhang, Lei Jiang, Zhaoyu Gao, Wenzhen Xia, Xiaoying Ma, Yushi Qin, Di Zhang, Jiazheng Li, Pei Tian and 6 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Journal of bacteriology · 2026
    Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Inhibition of colorectal cancer in Alzheimer's disease is mediated by gut microbiota via induction of inflammatory tolerance.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Nan Zhang *Central Laboratory, The First Hospital of Hebei Medical University, Shijiazhuang 050031, People's Republic of China.ORCID 0000-0002-6814-214X
Rui Zhang *Central Laboratory, The First Hospital of Hebei Medical University, Shijiazhuang 050031, People's Republic of China.
Lei JiangCentral Laboratory, The First Hospital of Hebei Medical University, Shijiazhuang 050031, People's Republic of China.ORCID 0000-0002-2922-0707
Zhaoyu GaoCentral Laboratory, The First Hospital of Hebei Medical University, Shijiazhuang 050031, People's Republic of China.ORCID 0009-0000-7972-8181
Wenzhen XiaCentral Laboratory, The First Hospital of Hebei Medical University, Shijiazhuang 050031, People's Republic of China.
Xiaoying MaCentral Laboratory, The First Hospital of Hebei Medical University, Shijiazhuang 050031, People's Republic of China.
Yushi QinCentral Laboratory, The First Hospital of Hebei Medical University, Shijiazhuang 050031, People's Republic of China.
Di ZhangCentral Laboratory, The First Hospital of Hebei Medical University, Shijiazhuang 050031, People's Republic of China.
Jiazheng LiCentral Laboratory, The First Hospital of Hebei Medical University, Shijiazhuang 050031, People's Republic of China.
Pei TianCentral Laboratory, The First Hospital of Hebei Medical University, Shijiazhuang 050031, People's Republic of China.
Qi ZhangCentral Laboratory, The First Hospital of Hebei Medical University, Shijiazhuang 050031, People's Republic of China.
Wanchang WangCentral Laboratory, The First Hospital of Hebei Medical University, Shijiazhuang 050031, People's Republic of China.
Kaixia ZhangCentral Laboratory, The First Hospital of Hebei Medical University, Shijiazhuang 050031, People's Republic of China.
Shan XuCentral Laboratory, The First Hospital of Hebei Medical University, Shijiazhuang 050031, People's Republic of China.
Na ZhaoCentral Laboratory, The First Hospital of Hebei Medical University, Shijiazhuang 050031, People's Republic of China.
Shunjiang XuCentral Laboratory, The First Hospital of Hebei Medical University, Shijiazhuang 050031, People's Republic of China.

Funding

CAMS Innovation Fund for Medical Sciences 2019-I2M-5-055Funding project for introducing overseas students of Hebei Province C20210346Hebei Natural Science Foundation H2018206358Hebei Natural Science Foundation H2020206105Hebei Province Government-funded Excellent Talents Project in Clinical Medicine ZF2023029Medical Science Research Project of Hebei Province 20211628MOST | National Natural Science Foundation of China (NSFC) 82100863Special Funding for Local Science and Technology Development Guided by the Central Government 206Z7701GThe Science and Technology project of the People's Livelihood in Hebei Province 20377707D
6 · The paper itself

Abstract

Epidemiological studies have revealed an inverse relationship between the incidence of Alzheimer's disease (AD) and various cancers, including colorectal cancer (CRC). We aimed to determine whether the incidence of CRC is reduced in AD-like mice and whether gut microbiota confers resistance to tumorigenesis through inducing inflammatory tolerance using 16S ribosomal RNA gene sequencing and fecal microbiota transplantation (FMT). AD-like mice experienced a significantly decreased incidence of CRC tumorigenesis induced by azoxymethane-dextran sodium sulfate as evidenced by suppressed intestinal inflammation compared with control mice. However, FMT from age-matched control mice reversed the inhibitory effects on the tumorigenesis of CRC and inflammatory response in AD-like mice. The key bacterial genera in gut microbiota, including

Indexed as

Alzheimer DiseaseColorectal NeoplasmsFecal Microbiota TransplantationGastrointestinal MicrobiomeAnimalsCarcinogenesisCognitive DysfunctionDextran SulfateDisease Models, AnimalFemaleHumansInflammationLipopolysaccharidesMaleMicePrevotellaDextran SulfateLipopolysaccharidesAlzheimer’s disease (AD)colorectal cancer (CRC)gut microbiotainflammatory toleranceLPS

Identifiers

PMID39226363
PMCPMC11406296

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.